Abound Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Abound Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109	Sell	3 -1	-25%	-$34	﹤0.01%	1266
2026 Q1	$133	Hold	4	–	–	﹤0.01%	1350
2025 Q4	$186	Hold	4	–	–	﹤0.01%	1209
2025 Q3	$140	Hold	4	–	–	﹤0.01%	1244
2025 Q2	$119	Hold	4	–	–	﹤0.01%	1209
2025 Q1	$120	Sell	4 -1	-20%	-$31	﹤0.01%	1186
2024 Q4	$144	Hold	5	–	–	﹤0.01%	1176
2024 Q3	$194	Sell	5 -2	-29%	-$71	﹤0.01%	1182
2024 Q2	$226	Sell	7 -3	-30%	-$104	﹤0.01%	1073
2024 Q1	$389	Hold	10	–	–	﹤0.01%	1013
2023 Q4	$308	Buy	+10	New	+$250	﹤0.01%	1149

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Abound Wealth Management's COLL Position: Q2 2026 in Review

Abound Wealth Management reduced its Collegium Pharmaceutical (COLL) stake by 25% in Q2 2026, selling an estimated $34 and leaving 3 shares worth $109. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Abound Wealth Management first reported a position in COLL in Q4 2023 and has held it in 11 quarters since. The position peaked at $389 in Q1 2024. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Abound Wealth Management held 3 shares of Collegium Pharmaceutical worth $109 as of Q2 2026.
Abound Wealth Management sold 1 Collegium Pharmaceutical share in Q2 2026, an estimated $34.
Collegium Pharmaceutical made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1266 holding.
Abound Wealth Management first reported a position in Collegium Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
Abound Wealth Management's Collegium Pharmaceutical position peaked at $389 in Q1 2024.
280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.